List of Figures:
Figure 1. Research Method Flow Chart 10
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 13
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 15
Figure 4. North America Digital PCR Market, 2021-2031, $ mn 17
Figure 5. Impact of COVID-19 on Business 20
Figure 6. Primary Drivers and Impact Factors of North America Digital PCR Market 22
Figure 7. Leading Causes of Death in the World, 2019-2020, million 25
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 26
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 26
Figure 10. Primary Restraints and Impact Factors of North America Digital PCR Market 28
Figure 11. Investment Opportunity Analysis 32
Figure 12. Porter’s Fiver Forces Analysis of North America Digital PCR Market 35
Figure 13. Breakdown of North America Digital PCR Market by Offering, 2021-2031, % of Revenue 40
Figure 14. North America Addressable Market Cap in 2022-2031 by Offering, Value ($ mn) and Share (%) 40
Figure 15. North America Digital PCR Market by Offering: Instruments & Accessories, 2021-2031, $ mn 41
Figure 16. North America Digital PCR Market by Offering: Reagents & Consumables, 2021-2031, $ mn 42
Figure 17. North America Digital PCR Market by Offering: Software & Services, 2021-2031, $ mn 43
Figure 18. Breakdown of North America Digital PCR Market by Technology, 2021-2031, % of Sales Revenue 45
Figure 19. North America Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%) 45
Figure 20. North America Digital PCR Market by Technology: Droplet Digital PCR, 2021-2031, $ mn 46
Figure 21. North America Digital PCR Market by Technology: Chip-based Digital PCR, 2021-2031, $ mn 47
Figure 22. North America Digital PCR Market by Technology: Beaming Digital PCR, 2021-2031, $ mn 48
Figure 23. North America Digital PCR Market by Technology: Other Technologies, 2021-2031, $ mn 49
Figure 24. Breakdown of North America Digital PCR Market by Application, 2021-2031, % of Sales Revenue 51
Figure 25. North America Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 51
Figure 26. North America Digital PCR Market by Application: Research, 2021-2031, $ mn 52
Figure 27. North America Digital PCR Market by Application: Clinical Diagnostics, 2021-2031, $ mn 53
Figure 28. North America Digital PCR Market by Clinical Diagnostics: Infectious diseases, 2021-2031, $ mn 55
Figure 29. North America Digital PCR Market by Clinical Diagnostics: Oncology, 2021-2031, $ mn 56
Figure 30. North America Digital PCR Market by Clinical Diagnostics: Genetic Disorders, 2021-2031, $ mn 57
Figure 31. North America Digital PCR Market by Clinical Diagnostics: Other Indications, 2021-2031, $ mn 58
Figure 32. North America Digital PCR Market by Application: Forensic Testing, 2021-2031, $ mn 59
Figure 33. North America Digital PCR Market by Application: Food and Agriculture, 2021-2031, $ mn 60
Figure 34. North America Digital PCR Market by Application: Other Applications, 2021-2031, $ mn 61
Figure 35. Breakdown of North America Digital PCR Market by End User, 2021-2031, % of Revenue 63
Figure 36. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 63
Figure 37. North America Digital PCR Market by End User: Hospitals and Clinics, 2021-2031, $ mn 64
Figure 38. North America Digital PCR Market by End User: Pharma & Biotech Companies, 2021-2031, $ mn 65
Figure 39. North America Digital PCR Market by End User: Diagnostic Centers, 2021-2031, $ mn 66
Figure 40. North America Digital PCR Market by End User: Other End Users, 2021-2031, $ mn 67
Figure 41. Breakdown of North America Digital PCR Market by Country, 2021 and 2031, % of Revenue 69
Figure 42. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 70
Figure 43. U.S. Digital PCR Market, 2021-2031, $ mn 72
Figure 44. Canada Digital PCR Market, 2021-2031, $ mn 74
Figure 45. Digital PCR Market in Mexico, 2021-2031, $ mn 76
Figure 46. Growth Stage of North America Digital PCR Industry over the Forecast Period 78
North America digital PCR (dPCR) market is projected to grow by 10.1% annually in the forecast period and reach $ 451.6 million by 2031, driven by the rise in prevalence of infectious diseases and cancer, growing awareness & acceptance of personalized medicines, technological advancements in diagnostic tools, and continuous increase in funding for R&D activities. Highlighted with 22 tables and 46 figures, this 95-page report “North America Digital PCR (dPCR) Market 2021-2031 by Offering (Instruments & Accessories, Reagents & Consumables, Software & Services), Technology (Droplet, Chip-based, Beaming, Others), Application (Research, Clinical Diagnostics, Forensic, Food and Agriculture, Others), End User (Hospitals and Clinics, Pharma & Biotech Companies, Diagnostic Centers, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America digital PCR (dPCR) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America digital PCR (dPCR) market in every aspect of the classification from perspectives of Offering, Technology, Application, End User, and Country. Based on Offering, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Instruments & Accessories • Reagents & Consumables • Software & Services Based on Technology, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Droplet Digital PCR • Chip-based Digital PCR • Beaming Digital PCR • Other Technologies By Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Research • Clinical Diagnostics o Infectious diseases o Oncology o Genetic Disorders o Other Indications • Forensic Testing • Food and Agriculture • Other Applications By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Hospitals and Clinics • Pharma & Biotech Companies • Diagnostic Centers • Other End Users Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Offering, Technology, and Application over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: 4basebio AG Bio-Rad Laboratories, Inc. Combinati, Inc. Fluidigm Corporation Formulatrix Inc. JN Medsys Merck KGaA Qiagen N.V RainDance Technologies Stilla Technologies Inc. Sysmex Corporation Thermo Fisher Scientific, Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More